Edition:
India

Cepi Awards $36 Million Contract To Profectus Biosciences And Emergent Biosolutions


Thursday, 16 Aug 2018 

Aug 16 (Reuters) - Emergent BioSolutions Inc ::CEPI AWARDS CONTRACT WORTH UP TO $36 MILLION TO PROFECTUS BIOSCIENCES AND EMERGENT BIOSOLUTIONS TO DEVELOP LASSA VIRUS VACCINE.COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS - AS PER CONTRACT, PROFECTUS WILL RECEIVE DEVELOPMENT FUNDING FROM CEPI FOR ADVANCING ITS LASSA VIRUS VACCINE. 

Company Quote

43.93
1.52 +3.58%
18 Jul 2019